SEARCH RESULTS

330986 RESULTS

Lon S. Schneider on PBT2 Takes a Dive in Phase 2 Alzheimer’s Trial

COMMENT The big picture here is that Prana’s only prior Phase 2 trial with PBT2 — completed in 2007 with 78 mild AD patients treated for 12 weeks — showed lower CSF Aβ42 and nominally significant effects on verbal fluency and working memory. A reasonable developm

Sam Patel


Professional Regulation, IIT Bombay
Mt Prospect, United States

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE